BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 36185249)

  • 1. Revisiting 'Hallmarks of Cancer' In Sarcomas.
    Honoki K; Tsujiuchi T; Kishi S; Kuniyasu H
    J Cancer; 2024; 15(7):1786-1804. PubMed ID: 38434982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hallmarks of a Cancer Discovery.
    Diaz LA; Cantley LC
    Cancer Discov; 2023 Apr; 13(4):797-798. PubMed ID: 37009701
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
    Raghuram GV; Pal K; Sriram G; Khan A; Joshi R; Jadhav V; Shinde S; Shaikh A; Rane B; Kangne H; Mittra I
    PLoS One; 2024; 19(2):e0298042. PubMed ID: 38346047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free chromatin particles released from dying cancer cells activate immune checkpoints in human lymphocytes: implications for cancer therapy.
    Shabrish S; Pal K; Khare NK; Satsangi D; Pilankar A; Jadhav V; Shinde S; Raphael N; Sriram G; Lopes R; Raghuram GV; Tandel H; Mittra I
    Front Immunol; 2023; 14():1331491. PubMed ID: 38274821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells.
    Raghuram GV; Tripathy BK; Avadhani K; Shabrish S; Khare NK; Lopes R; Pal K; Mittra I
    Cell Death Discov; 2024 Jan; 10(1):30. PubMed ID: 38225229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis.
    Gnocchi D; Nikolic D; Paparella RR; Sabbà C; Mazzocca A
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Antioxidant Vitamins and Other Micronutrients on Regulations of Specific Genes and Signaling Pathways in the Prevention and Treatment of Cancer.
    Fagbohun OF; Gillies CR; Murphy KPJ; Rupasinghe HPV
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice.
    Pal K; Raghuram GV; Dsouza J; Shinde S; Jadhav V; Shaikh A; Rane B; Tandel H; Kondhalkar D; Chaudhary S; Mittra I
    Sci Rep; 2022 Oct; 12(1):17209. PubMed ID: 36241685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study).
    Ostwal V; Ramaswamy A; Bhargava P; Srinivas S; Mandavkar S; Chaugule D; Peelay Z; Baheti A; Tandel H; Jadhav VK; Shinde S; Jadhav S; Gota V; Mittra I
    Med Oncol; 2022 Nov; 40(1):17. PubMed ID: 36372825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the damaging effects of ROS for therapeutic use by deactivating cell-free chromatin: the alchemy of resveratrol and copper.
    Mittra I
    Front Pharmacol; 2024; 15():1345786. PubMed ID: 38455966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of tumour-derived exosomes to the hallmarks of cancer.
    Meehan K; Vella LJ
    Crit Rev Clin Lab Sci; 2016; 53(2):121-31. PubMed ID: 26479834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004).
    Pilankar A; Singhavi H; Raghuram GV; Siddiqui S; Khare NK; Jadhav V; Tandel H; Pal K; Bhattacharjee A; Chaturvedi P; Mittra I
    Front Oncol; 2022; 12():1000957. PubMed ID: 36185249
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.